Assessing longitudinal trends in cardiac function among pediatric patients with chronic kidney disease

Ylva Tranæus Lindblad1,2, Georgios Vavilis3, Jonas Axelsson4,5

  • 1Division of Pediatrics, Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden. ylva.tranaeus-lindblad@karolinska.se.

Insights

Pediatric chronic kidney disease (CKD) patients show early left ventricular diastolic dysfunction (LVDD). Elevated systolic blood pressure predicts worsening diastolic function, indicating potential for interventions in pediatric CKD and kidney transplant (CKD-T) patients.

Area of Science:

  • Pediatric Nephrology
  • Cardiology
  • Echocardiography

Background:

  • Left ventricular diastolic dysfunction (LVDD) is an early indicator of cardiac disease in pediatric chronic kidney disease (CKD).
  • Longitudinal trends of LVDD in pediatric CKD and kidney transplant (CKD-T) patients are not well-studied.
  • This study prospectively followed pediatric CKD and CKD-T patients for 3 years.

Purpose of the Study:

  • To analyze longitudinal trends of LVDD in pediatric CKD and CKD-T patients.
  • To identify predictive risk factors for cardiac disease progression.
  • To compare the diagnostic potential of tissue Doppler imaging (TDI) and pulse wave Doppler (PWD) for LVDD.

Main Methods:

  • Prospective 3-year follow-up study of 30 CKD and 42 CKD-T patients.
  • Annual clinical and echocardiographic assessments using TDI and PWD.
  • Multivariate modeling to identify associations with predictive risk factors.

Main Results:

  • Prevalence of LVDD by TDI (lateral z-score e') was 7.1% in CKD and 12.5% in CKD-T patients.
  • Prevalence of LVDD by PWD E was 3.3% in CKD and 2.4% in CKD-T patients.
  • Diastolic function markers (TDI and PWD) worsened over time; elevated systolic ambulatory blood pressure was the strongest predictor of cardiac disease after adjustments.

Conclusions:

  • Children with CKD exhibit early signs of LVDD.
  • TDI is more sensitive than PWD for diagnosing LVDD in this population.
  • Increased ambulatory systolic blood pressure predicts progression of diastolic dysfunction, suggesting targets for intervention.
Abstract

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
581
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
909
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
310
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.3K